MyMD Pharmaceuticals Inc.

NASDAQ: MYMD · Real-Time Price · USD
1.81
-0.01 (-0.55%)
At close: Jul 23, 2024, 9:30 PM

MyMD Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a
Cost of Revenue
n/a n/a n/a
Gross Profit
n/a n/a n/a
Operating Income
-17.12M -15.28M -28.81M
Interest Income
n/a 83.99K 8.91K
Pretax Income
-4M -15.2M -29.89M
Net Income
-4M -15.2M -29.89M
Selling & General & Admin
8.49M 6.21M 21.46M
Research & Development
7.87M 9.07M 6.75M
Other Expenses
-763K n/a n/a
Operating Expenses
17.12M 15.28M 6.75M
Interest Expense
n/a n/a 608.46K
Selling & Marketing Expenses
8.49M n/a n/a
Cost & Expenses
17.12M 15.28M 28.2M
Income Tax Expense
n/a -85.43K -8.91K
Shares Outstanding (Basic)
20.48M 38.83M 35.02M
Shares Outstanding (Diluted)
20.48M 38.83M 35.02M
EPS (Basic)
-0.2 -11.68 -25.6
EPS (Diluted)
-0.2 -11.68 -25.6
EBITDA
-17.12M 85.43K -28.81M
EBIT
n/a n/a -29.28M
Depreciation & Amortization
16.36M 83.99K 617.37K